Detalhe da pesquisa
1.
Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch.
Hum Immunol
; 74(12): 1616-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23994588